August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Myeloma Paper of the Day, August 1st, Suggested by Robert Orlowski
Aug 1, 2025, 11:48

Myeloma Paper of the Day, August 1st, Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day:

Named Patient Program data from Korea on teclistamab show ORR 66.7% (28/42), 40.5% CR rate, median PFS 14.1 months (3.1 if R-ISS III), 12-month OS 61.7% with disease progression and infection as most common causes of death.”

Title: Real-World Efficacy and Safety of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma: Nationwide Retrospective Analysis of the Named Patient Program in Korea

Authors: Jun Ho Yi, Jae Hoon Lee, Sung-Hoon Jung, Ji Hyun Lee, Ji Yun Lee, Kihyun Kim, Sung-Soo Park, Chang-Ki Min, Yoon Seok Choi, Min Kyoung Kim, Ho-Young Yhim, Dok Hyun Yoon

You can read the Full Article on Cancer Research and Treatment.

Myeloma Paper of the Day, August 1st, Suggested by Robert Orlowski

You can find more posts featuring Robert Orlowski on OncoDaily.